Biography
Dr. Arturo Loaiza-Bonilla, MD, MSEd, FACP is a physician–scientist and oncology executive operating at the intersection of clinical medicine, artificial intelligence, and large-scale clinical research infrastructure.
Clinical interests / subspecialty
Biomarker-driven cancers; immunotherapy; complex trial-based care; clinical trial access/matching infrastructure; neurosymbolic & multi-agent AI platforms
Education & training
Medical School: University of Miami Miller School of Medicine
Residency: St. Luke's-Roosevelt Hospital Center, Columbia University, Internal Medicine
Fellowship: Post-Doctorate Fellow, Hematology and Oncology (University of Miami Miller School of Medicine)
Other training: Master of Medical Education (MSEd), Medical Education (University of Pennsylvania)
Board certifications / licenses
- ABIM - Medical Oncology
- ABIM - Internal Medicine
Professional memberships
ASCO, AACR, ACP (Fellow)
Languages
English (native); French (professional working proficiency); Japanese (elementary proficiency); Spanish (native or bilingual proficiency)
Research areas
AI in clinical trials; neurosymbolic / multi-agent AI architectures; digital health; real-world data activation; precision oncology systems
Clinical research experience
Phase I–III clinical trial leadership and portfolios across oncology networks
Leadership & recognition
- 40 under 40 in Cancer; Philadelphia Business Journal “40 Under 40”; Castle Connolly / Philadelphia Magazine Top Doctors (since 2018)
Publications & media
- 80+ peer-reviewed publications in NEJM AI, JCO, Lancet Oncology, ESMO and JAMA Oncology
- PubMed
Arturo Loaiza-Bonilla reviews Massive Bio content as part of our Medical Review Board, ensuring medical accuracy and clinical currency across our cancer resources.
Content reviewed by Arturo Loaiza-Bonilla
Symptômes du cancer du poumon de stade 1 : quand consulter un médecin
MAY 2025
Témoignages Réels : Comment j’ai découvert que j’avais un cancer du poumon
MAY 2025
Décryptage des taux de survie du cancer du poumon selon l’âge et le stade
MAY 2025
Qu’est-ce que la myélofibrose
MAY 2025
Cancer du sein inflammatoire au stade précoce : à quoi cela ressemble-t-il
MAY 2025
Symptômes rares du cancer du poumon que vous ne devez pas ignorer
MAY 2025
Comprendre le pronostic du myélome multiple : quels sont les facteurs les plus importants?
APRIL 2025
Comment la localisation de la tumeur influence le traitement du cancer du poumon à petites cellules
APRIL 2025
Massive Bio reçoit son attestation de certification par la CNIL pour sa mise en conformité au RGPD !
APRIL 2025
Tumeur au Cerveau : Guide Simple pour Comprendre Votre Diagnostic
FEBRUARY 2025
Fibromes Utérins : Symptômes, Traitements et Options Médicales
FEBRUARY 2025
Métastases Osseuses: Symptômes et Options de Traitement
JANUARY 2025
Understanding Lung Adenocarcinoma: Symptoms and Treatments
JANUARY 2025
Adénocarcinome Pulmonaire : Symptômes, Traitements et Évolution
JANUARY 2025
Comment Prévenir le Cancer du Côlon : 5 Conseils Essentiels
DECEMBER 2024
J’ai guéri du cancer du pancréas
NOVEMBER 2024
Cancer Ovaire Symptome
OCTOBER 2024
Cancer Amygdale
OCTOBER 2024
Symptome Cancer Estomac
OCTOBER 2024
Albumine Cancer
OCTOBER 2024
Refusing Hormone Therapy For Breast Cancer : What To Know
SEPTEMBER 2024
Cancer Urothélial
SEPTEMBER 2024
Syndrome Myélodysplasique
SEPTEMBER 2024
Cancer De l’utérus Symptome Stade 1
SEPTEMBER 2024